Latest filing published 03 Jun 2026 for Lantheus Holdings, Inc., €32k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Gerard Ber, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Lantheus Holdings, Inc., Y-mAbs Therapeutics, Inc. and Progenics Pharmaceuticals Inc. Over a trading history stretching from 19 June 2020 to 14 May 2026, the count stands at 20 filings.
Sales make up the whole of the open-market record (5 sales, €1.4M). Besides market trades, the filings include 14 share grants.
On 3 June 2026 came the latest disclosure, a share grant for €32k in Lantheus Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations